Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent applications Proprietary sensing and ...
PEMGARDAâ„¢ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 ...